PensionDanmark Pensionsforsikringsaktieselskab Has $26.73 Million Holdings in Intuitive Surgical, Inc. $ISRG

PensionDanmark Pensionsforsikringsaktieselskab lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 15.9% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 67,208 shares of the medical equipment provider’s stock after acquiring an additional 9,212 shares during the period. PensionDanmark Pensionsforsikringsaktieselskab’s holdings in Intuitive Surgical were worth $26,727,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Newbridge Financial Services Group Inc. boosted its stake in Intuitive Surgical by 300.0% in the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 33 shares during the period. Laurel Wealth Advisors LLC acquired a new stake in shares of Intuitive Surgical in the 4th quarter valued at about $31,000. Turning Point Benefit Group Inc. raised its stake in shares of Intuitive Surgical by 833.3% in the 4th quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider’s stock valued at $32,000 after purchasing an additional 50 shares during the period. Motiv8 Investments LLC bought a new stake in shares of Intuitive Surgical in the fourth quarter valued at about $34,000. Finally, Oakworth Capital Inc. lifted its holdings in shares of Intuitive Surgical by 281.2% in the fourth quarter. Oakworth Capital Inc. now owns 61 shares of the medical equipment provider’s stock valued at $35,000 after purchasing an additional 45 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Intuitive Surgical

In related news, SVP Iman Jeddi sold 5,625 shares of the business’s stock in a transaction on Monday, June 1st. The shares were sold at an average price of $420.55, for a total transaction of $2,365,593.75. Following the transaction, the senior vice president directly owned 6,463 shares in the company, valued at approximately $2,718,014.65. The trade was a 46.53% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the company’s stock in a transaction on Wednesday, June 10th. The stock was sold at an average price of $424.14, for a total transaction of $169,656.00. Following the sale, the executive vice president directly owned 5,720 shares in the company, valued at $2,426,080.80. This trade represents a 6.54% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 6,634 shares of company stock valued at $2,796,795 over the last three months. 0.60% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on ISRG shares. BNP Paribas Exane upgraded Intuitive Surgical to an “outperform” rating in a report on Tuesday, July 28th. Sanford C. Bernstein cut their target price on Intuitive Surgical from $750.00 to $685.00 and set an “outperform” rating on the stock in a research note on Friday, July 17th. HSBC downgraded Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 price target for the company. in a research report on Thursday, July 30th. UBS Group began coverage on shares of Intuitive Surgical in a report on Tuesday, July 28th. They issued a “neutral” rating and a $500.00 price objective on the stock. Finally, Jefferies Financial Group cut their price objective on shares of Intuitive Surgical from $560.00 to $515.00 and set a “hold” rating on the stock in a research report on Wednesday, April 22nd. Twenty analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $509.02.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $373.71 on Friday. The stock has a 50 day moving average price of $393.78 and a 200 day moving average price of $446.25. The stock has a market capitalization of $132.02 billion, a PE ratio of 42.81, a price-to-earnings-growth ratio of 2.71 and a beta of 1.46. Intuitive Surgical, Inc. has a 52 week low of $328.57 and a 52 week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share for the quarter, topping the consensus estimate of $2.48 by $0.32. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.The firm had revenue of $2.89 billion for the quarter, compared to analyst estimates of $2.83 billion. During the same quarter in the previous year, the firm earned $1.81 EPS. The business’s quarterly revenue was up 18.4% on a year-over-year basis. As a group, research analysts forecast that Intuitive Surgical, Inc. will post 8.87 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.